GloBE-Reg is an international registry project that can support post-regulatory approval studies for multiple novel therapies for conditions affecting endocrine or bone health. The stakeholders of this project include patient, professional and scientific organisations as well as industry.
GloBE-Reg receives research support funding from Novo Nordisk and the University of Glasgow
The GloBE-Reg Registry is now live. Access the Registry
GloBE-Reg Drop-in sessions
Come along to our first drop-in sessions for a live walkthrough of the Registry
Session Timetable and Zoom link
GloBE-Reg Latest News
The registry went live in October 2022 and is ready for use. The Growth Hormone Scientific Study Group members, working with the Project Management Group, have begun the process of getting local approvals for their centres. You can access the registry here: https://globe-reg.net/registry/ If you have any questions please email firstname.lastname@example.org.
Brad Miller presented a poster titled: The Growth Hormone Study Module For Paediatric Growth Hormone Deficiency‐ In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions (GloBE‐Reg) on behalf of the GloBE-Reg Growth Hormone Scientific Study Group at the ESPE conference in Rome. To view the pdf of the poster click here.… Continue reading GloBE-Reg Poster at ESPE
We successfully held our first face-to-face joint meeting in Rome and were pleased to have representatives from the Steering Committee, GH Scientific Study Group, Data Access Committee and Industry Partners in attendance.
Get in Touch
We are very excited about this new project and are in the process of building this website. If you would like to find out more right now, feel free to contact email@example.com.
You can also follow us on Twitter: https://twitter.com/GloBE_Reg.